Literature DB >> 27402494

Glial and Neuroimmune Mechanisms as Critical Modulators of Drug Use and Abuse.

Michael J Lacagnina1, Phillip D Rivera1, Staci D Bilbo1.   

Abstract

Drugs of abuse cause persistent alterations in synaptic plasticity that may underlie addiction behaviors. Evidence suggests glial cells have an essential and underappreciated role in the development and maintenance of drug abuse by influencing neuronal and synaptic functions in multifaceted ways. Microglia and astrocytes perform critical functions in synapse formation and refinement in the developing brain, and there is growing evidence that disruptions in glial function may be implicated in numerous neurological disorders throughout the lifespan. Linking evidence of function in health and under pathological conditions, this review will outline the glial and neuroimmune mechanisms that may contribute to drug-abuse liability, exploring evidence from opioids, alcohol, and psychostimulants. Drugs of abuse can activate microglia and astrocytes through signaling at innate immune receptors, which in turn influence neuronal function not only through secretion of soluble factors (eg, cytokines and chemokines) but also potentially through direct remodeling of the synapses. In sum, this review will argue that neural-glial interactions represent an important avenue for advancing our understanding of substance abuse disorders.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27402494      PMCID: PMC5143481          DOI: 10.1038/npp.2016.121

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  260 in total

Review 1.  Brain macrophages: evaluation of microglia and their functions.

Authors:  W E Thomas
Journal:  Brain Res Brain Res Rev       Date:  1992 Jan-Apr

2.  Immunohistochemical localization of macrophages and microglia in the adult and developing mouse brain.

Authors:  V H Perry; D A Hume; S Gordon
Journal:  Neuroscience       Date:  1985-06       Impact factor: 3.590

Review 3.  The role of inflammation in depression: from evolutionary imperative to modern treatment target.

Authors:  Andrew H Miller; Charles L Raison
Journal:  Nat Rev Immunol       Date:  2016-01       Impact factor: 53.106

4.  Morphine-induced chemotaxis and brain-derived neurotrophic factor expression in microglia.

Authors:  Naoko Takayama; Hiroshi Ueda
Journal:  J Neurosci       Date:  2005-01-12       Impact factor: 6.167

5.  Evidence for addiction-like behavior in the rat.

Authors:  Véronique Deroche-Gamonet; David Belin; Pier Vincenzo Piazza
Journal:  Science       Date:  2004-08-13       Impact factor: 47.728

6.  Interleukin-10 gene polymorphism is associated with alcoholism but not with alcoholic liver disease.

Authors:  Miguel Marcos; Isabel Pastor; Rogelio González-Sarmiento; Francisco Javier Laso
Journal:  Alcohol Alcohol       Date:  2008-04-24       Impact factor: 2.826

7.  Methamphetamine causes microglial activation in the brains of human abusers.

Authors:  Yoshimoto Sekine; Yasuomi Ouchi; Genichi Sugihara; Nori Takei; Etsuji Yoshikawa; Kazuhiko Nakamura; Yasuhide Iwata; Kenji J Tsuchiya; Shiro Suda; Katsuaki Suzuki; Masayoshi Kawai; Kiyokazu Takebayashi; Shigeyuki Yamamoto; Hideo Matsuzaki; Takatoshi Ueki; Norio Mori; Mark S Gold; Jean L Cadet
Journal:  J Neurosci       Date:  2008-05-28       Impact factor: 6.167

8.  Corticotropin releasing factor-induced amygdala gamma-aminobutyric Acid release plays a key role in alcohol dependence.

Authors:  Marisa Roberto; Maureen T Cruz; Nicholas W Gilpin; Valentina Sabino; Paul Schweitzer; Michal Bajo; Pietro Cottone; Samuel G Madamba; David G Stouffer; Eric P Zorrilla; George F Koob; George R Siggins; Loren H Parsons
Journal:  Biol Psychiatry       Date:  2010-01-08       Impact factor: 13.382

Review 9.  Reward and aversion in a heterogeneous midbrain dopamine system.

Authors:  Stephan Lammel; Byung Kook Lim; Robert C Malenka
Journal:  Neuropharmacology       Date:  2013-04-08       Impact factor: 5.250

Review 10.  Neuroinflammation in Alzheimer's disease.

Authors:  Michael T Heneka; Monica J Carson; Joseph El Khoury; Gary E Landreth; Frederic Brosseron; Douglas L Feinstein; Andreas H Jacobs; Tony Wyss-Coray; Javier Vitorica; Richard M Ransohoff; Karl Herrup; Sally A Frautschy; Bente Finsen; Guy C Brown; Alexei Verkhratsky; Koji Yamanaka; Jari Koistinaho; Eicke Latz; Annett Halle; Gabor C Petzold; Terrence Town; Dave Morgan; Mari L Shinohara; V Hugh Perry; Clive Holmes; Nicolas G Bazan; David J Brooks; Stéphane Hunot; Bertrand Joseph; Nikolaus Deigendesch; Olga Garaschuk; Erik Boddeke; Charles A Dinarello; John C Breitner; Greg M Cole; Douglas T Golenbock; Markus P Kummer
Journal:  Lancet Neurol       Date:  2015-04       Impact factor: 44.182

View more
  89 in total

Review 1.  The role of neuroimmune signaling in alcoholism.

Authors:  Fulton T Crews; Colleen J Lawrimore; T Jordan Walter; Leon G Coleman
Journal:  Neuropharmacology       Date:  2017-02-01       Impact factor: 5.250

Review 2.  Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease.

Authors:  S M Matt; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2019-05-11       Impact factor: 4.147

3.  The Immunology of Behavior-Exploring the Role of the Immune System in Brain Health and Illness.

Authors:  Andrew H Miller; Ebrahim Haroon; Jennifer C Felger
Journal:  Neuropsychopharmacology       Date:  2017-01       Impact factor: 7.853

4.  Cocaine-Mediated Downregulation of miR-124 Activates Microglia by Targeting KLF4 and TLR4 Signaling.

Authors:  Palsamy Periyasamy; Ke Liao; Yeon Hee Kook; Fang Niu; Shannon E Callen; Ming-Lei Guo; Shilpa Buch
Journal:  Mol Neurobiol       Date:  2017-05-06       Impact factor: 5.590

Review 5.  Neuroinflammation in addiction: A review of neuroimaging studies and potential immunotherapies.

Authors:  Milky Kohno; Jeanne Link; Laura E Dennis; Holly McCready; Marilyn Huckans; William F Hoffman; Jennifer M Loftis
Journal:  Pharmacol Biochem Behav       Date:  2019-01-26       Impact factor: 3.533

6.  Characterization of the Hippocampal Neuroimmune Response to Binge-Like Ethanol Consumption in the Drinking in the Dark Model.

Authors:  Isabella R Grifasi; Scot E McIntosh; Rhiannon D Thomas; Donald T Lysle; Todd E Thiele; S Alex Marshall
Journal:  Neuroimmunomodulation       Date:  2019-01-09       Impact factor: 2.492

7.  Tobacco Smoking in People Is Not Associated with Altered 18-kDa Translocator Protein Levels: A PET Study.

Authors:  Ansel T Hillmer; David Matuskey; Yiyun Huang; Nabeel Nabulsi; Jim Ropchan; Richard E Carson; Stephanie S O'Malley; Kelly P Cosgrove
Journal:  J Nucl Med       Date:  2020-01-31       Impact factor: 10.057

8.  The efficacy of (+)-Naltrexone on alcohol preference and seeking behaviour is dependent on light-cycle.

Authors:  Jonathan Henry W Jacobsen; Femke T A Buisman-Pijlman; Sanam Mustafa; Kenner C Rice; Mark R Hutchinson
Journal:  Brain Behav Immun       Date:  2017-08-30       Impact factor: 7.217

9.  Dorsal hippocampal neural immune signaling regulates heroin-conditioned immunomodulation but not heroin-conditioned place preference.

Authors:  Jacqueline E Paniccia; Christina L Lebonville; Meghan E Jones; Shveta V Parekh; Rita A Fuchs; Donald T Lysle
Journal:  Brain Behav Immun       Date:  2018-07-31       Impact factor: 7.217

10.  Dorsal hippocampal interleukin-1 signaling mediates heroin withdrawal-enhanced fear learning.

Authors:  Shveta V Parekh; Jacqueline E Paniccia; Christina L Lebonville; Donald T Lysle
Journal:  Psychopharmacology (Berl)       Date:  2020-08-28       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.